What is the price-to-earnings ratio of CEL-SCI?
The price-earnings ratio of CEL-SCI is currently 619.92.
CEL-SCI P/S 2024
CEL-SCI P/S
619.92
Ticker
CVM
ISIN
US1508376076
WKN
A2DY0D
As of Sep 14, 2024, CEL-SCI's P/S ratio stood at 619.92, a 0% change from the 0 P/S ratio recorded in the previous year.
The CEL-SCI P/S history
CEL-SCI Aktienanalyse
What does CEL-SCI do?
CEL-SCI Corp is a biotechnology company specializing in the development of immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1983 and is headquartered in Virginia, USA. CEL-SCI ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding CEL-SCI's P/S Ratio
CEL-SCI's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing CEL-SCI's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating CEL-SCI's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in CEL-SCI’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about CEL-SCI stock
How has the price-earnings ratio of CEL-SCI changed compared to last year?
The price-to-earnings ratio of CEL-SCI has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of CEL-SCI high compared to other companies?
Yes, the price-to-earnings ratio of CEL-SCI is high compared to other companies.
How does an increase in the price-earnings ratio of CEL-SCI affect the company?
An increase in the price-earnings ratio of CEL-SCI would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of CEL-SCI affect the company?
A decrease in the price-earnings ratio of CEL-SCI would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of CEL-SCI?
Some factors that influence the price-earnings ratio of CEL-SCI are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does CEL-SCI pay?
Over the past 12 months, CEL-SCI paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CEL-SCI is expected to pay a dividend of 0 USD.
What is the dividend yield of CEL-SCI?
The current dividend yield of CEL-SCI is .
When does CEL-SCI pay dividends?
CEL-SCI pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of CEL-SCI?
CEL-SCI paid dividends every year for the past 0 years.
What is the dividend of CEL-SCI?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is CEL-SCI located?
CEL-SCI is assigned to the 'Health' sector.
Wann musste ich die Aktien von CEL-SCI kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CEL-SCI from 9/14/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/14/2024.
When did CEL-SCI pay the last dividend?
The last dividend was paid out on 9/14/2024.
What was the dividend of CEL-SCI in the year 2023?
In the year 2023, CEL-SCI distributed 0 USD as dividends.
In which currency does CEL-SCI pay out the dividend?
The dividends of CEL-SCI are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von CEL-SCI
Our stock analysis for CEL-SCI Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CEL-SCI Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
